Cassava Sciences (SAVA)

• Market cap: $82.1M
• 1 day: -2.86%
• 5 days: -37.27%
• 1 month: -34.62%
• 3 months: -32.00%
• 6 months: -94.03%
• Year to date: -38.18%
• 1 year: -91.67%
• 5 years: -44.08%
• 10 years: -81.32%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

26% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 35

6.87% more ownership

Funds ownership: 29.27% [Q3] → 36.13% (+6.87%) [Q4]

14% less funds holding

Funds holding: 160 [Q3] → 137 (-23) [Q4]

38% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 52

63% less call options, than puts

Call options by funds: $10.1M | Put options by funds: $27.2M

87% less capital invested

Capital invested by funds: $412M [Q3] → $51.8M (-$360M) [Q4]

100% less funds holding in top 10

Funds holding in top 10: 1 [Q3] → 0 (-1) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $2 18% upside
• Avg. target: $2 18% upside
• High target: $2 18% upside

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

HC Wainwright & Co. Vernon Bernardino 24% 1-year accuracy 16 / 67 met price target

18% upside $2

Neutral Reiterated

25 Mar 2025